$0.8200
-0.0003-0.04%
At close: Nov 13, 4:00 PM EST
IN8bio Inc
INABNASDAQ
IN8bio fell 48.4% from $1.59 to $0.82, behind the S&P 500's +13.3%. Its worst day was Mar 23 (−17.0%), and its low came Nov 13 at $0.82.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
IN8bio shares rose 15.3%, while the S&P 500 rose 1.5%.
+15.3% · S&P 500 +1.5%
Story events cover the past 12 months · Times ET
IN8bio shares rose 28.1%, while the S&P 500 rose 0.6%.
+28.1%, the year's best day · S&P 500 +0.6%
IN8bio shares rose 15.9%, while the S&P 500 fell 0.1%.
+15.9% · S&P 500 −0.1%
IN8bio closed at its highest level of the year, 62.9% above where the year started.
+11.6% · S&P 500 −0.1%
EPS of $-0.26 beat the $-0.36 estimate on $0.00 revenue.
−3.1% · S&P 500 −0.6%
IN8bio shares fell 17.0%, while the S&P 500 rose 1.1%.
−17.0%, the year's worst day · S&P 500 +1.1%
EPS of $-0.26 beat the $-0.67 estimate on $0.00 revenue.
−1.2% · S&P 500 +0.8%
EPS of $-0.25 beat the $-0.42 estimate on $0.00 revenue.
+0.5% · S&P 500 +0.6%
EPS of $-0.24 beat the $-0.38 estimate on $0.00 revenue.
+11.6% · S&P 500 +0.3%
Where it ended: a close of $0.82 on Nov 13, 2026. Up next: Q4 2026 earnings on Mar 11, 2027 (EPS est. $-0.41).
Nothing in the past 12 months.
All INAB analyst actionsNothing in the past 12 months.
All INAB dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INAB and SPY from Benzinga historical bars. Not investment advice.
